Viamet Pharmaceuticals Holdings LLC - FORM S-1 - EX-23.1 - April 8, 2016

Attached files

file filename
S-1 - S-1 - Viamet Pharmaceuticals Holdings LLCd117508ds1.htm
EX-4.1 - EX-4.1 - Viamet Pharmaceuticals Holdings LLCd117508dex41.htm
EX-4.2 - EX-4.2 - Viamet Pharmaceuticals Holdings LLCd117508dex42.htm
EX-3.3 - EX-3.3 - Viamet Pharmaceuticals Holdings LLCd117508dex33.htm
EX-3.4 - EX-3.4 - Viamet Pharmaceuticals Holdings LLCd117508dex34.htm
EX-1.1 - EX-1.1 - Viamet Pharmaceuticals Holdings LLCd117508dex11.htm
EX-2.2 - EX-2.2 - Viamet Pharmaceuticals Holdings LLCd117508dex22.htm
EX-3.2 - EX-3.2 - Viamet Pharmaceuticals Holdings LLCd117508dex32.htm
EX-2.1 - EX-2.1 - Viamet Pharmaceuticals Holdings LLCd117508dex21.htm
EX-10.2 - EX-10.2 - Viamet Pharmaceuticals Holdings LLCd117508dex102.htm
EX-10.7 - EX-10.7 - Viamet Pharmaceuticals Holdings LLCd117508dex107.htm
EX-10.8 - EX-10.8 - Viamet Pharmaceuticals Holdings LLCd117508dex108.htm
EX-10.4 - EX-10.4 - Viamet Pharmaceuticals Holdings LLCd117508dex104.htm
EX-10.3 - EX-10.3 - Viamet Pharmaceuticals Holdings LLCd117508dex103.htm
EX-10.9 - EX-10.9 - Viamet Pharmaceuticals Holdings LLCd117508dex109.htm
EX-10.6 - EX-10.6 - Viamet Pharmaceuticals Holdings LLCd117508dex106.htm
EX-99.1 - EX-99.1 - Viamet Pharmaceuticals Holdings LLCd117508dex991.htm
EX-21.1 - EX-21.1 - Viamet Pharmaceuticals Holdings LLCd117508dex211.htm
EX-10.5 - EX-10.5 - Viamet Pharmaceuticals Holdings LLCd117508dex105.htm
EX-10.10 - EX-10.10 - Viamet Pharmaceuticals Holdings LLCd117508dex1010.htm
EX-10.11 - EX-10.11 - Viamet Pharmaceuticals Holdings LLCd117508dex1011.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 9, 2016, in the Registration Statement (Form S-1) and related Prospectus of Viamet Pharmaceuticals Holdings, LLC for the registration of shares of its common stock.

/s/ Ernst & Young

Raleigh, North Carolina

April 7, 2016